Dorsey Brian
SEC CIK 1380762 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SPRY | ARS Pharmaceuticals, Inc. | COO | 32.6K | — | $1.82M | 8 | 2024-08-13 | 2025-11-13 |
Most active insiders at SPRY, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Chakma Justin | Chief Business Off | — | $1.48M |
| 2 | Karas Eric | Chief Commercial Off | — | $250.0K |
| 3 | Dorsey Brian | COO | — | $190.1K |
| 4 | Fitzpatrick Alexander A | CLO | — | $33.5K |
| 5 | Shah Pratik | Dir | — | — |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-11-14 | 2025-11-13 | SPRY | ARS Pharmaceuticals, Inc. | Dorsey Brian | COO | M - OptEx | $0.64 | +21.8K | 32.6K | +202% | +$14.0K |
| D | 2025-11-14 | 2025-11-13 | SPRY | ARS Pharmaceuticals, Inc. | Dorsey Brian | COO | S - Sale+OE | $8.71 | -21.8K | 10.8K | -67% | -$190.1K |
| DM | 2024-12-13 | 2024-12-11+ | SPRY | ARS Pharmaceuticals, Inc. | Dorsey Brian | COO | M - OptEx | $0.64 | +40.0K | 31.0K | New | +$25.6K |
| DM | 2024-12-13 | 2024-12-11+ | SPRY | ARS Pharmaceuticals, Inc. | Dorsey Brian | COO | S - Sale+OE | $12.35 | -40.0K | 6,024 | -87% | -$494.0K |
| D | 2024-08-21 | 2024-08-20 | SPRY | ARS Pharmaceuticals, Inc. | Dorsey Brian | COO | M - OptEx | $0.64 | +50.0K | 56.0K | +830% | +$32.0K |
| D | 2024-08-21 | 2024-08-20 | SPRY | ARS Pharmaceuticals, Inc. | Dorsey Brian | COO | S - Sale+OE | $15.00 | -50.0K | 6,024 | -89% | -$750.0K |
| D | 2024-08-15 | 2024-08-13 | SPRY | ARS Pharmaceuticals, Inc. | Dorsey Brian | COO | S - Sale+OE | $13.00 | -30.0K | 6,024 | -83% | -$390.0K |
| D | 2024-08-15 | 2024-08-13 | SPRY | ARS Pharmaceuticals, Inc. | Dorsey Brian | COO | M - OptEx | $0.64 | +30.0K | 36.0K | +498% | +$19.2K |
Purchase Sale Sale after option exercise All abbreviations